Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC10A1 | Q14973 | 18/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30361300 | 1.00 | SLC10A1 (0.65) | SLC10A1SMN1; SMN2 | |
| SCHEMBL21427908 | 1.00 | SLC10A1 (0.65) | SLC10A1SMN1; SMN2 | |
| SCHEMBL28484402 | 0.93 | SLC10A1 (0.65) | SLC10A1SMN1; SMN2 | |
| SCHEMBL21427878 | 0.93 | SLC10A1 (0.65) | SLC10A1SMN1; SMN2 | |
| SCHEMBL25645193 | 0.90 | SLC10A1 (0.54) | SLC10A1SMN1; SMN2 | |
| SCHEMBL21408333 | 0.88 | SLC10A1 (0.52) | SLC10A1 | |
| SCHEMBL21408330 | 0.88 | SLC10A1 (0.52) | SLC10A1 | |
| SCHEMBL30361254 | 0.88 | SLC10A1 (0.52) | SLC10A1 | |
| SCHEMBL21427863 | 0.88 | SLC10A1 (0.52) | SLC10A1 | |
| SCHEMBL22906129 | 0.83 | SLC10A1 (0.54) | SLC10A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115974753-A | N-containing heterocyclic five-membered ring compound and application | 正大天晴药业集团股份有限公司 | 2023-04-18 | — | — | CN | disclosed |
| CN-115974754-A | N-containing heterocyclic five-membered ring compound and application | 正大天晴药业集团股份有限公司 | 2023-04-18 | — | — | CN | disclosed |
| CN-111868026-A | Capsid protein assembly inhibitor containing N-heterocyclic five-membered ring, pharmaceutical composition and application thereof | 正大天晴药业集团股份有限公司 | 2020-10-30 | — | — | CN | disclosed |